icic 2014 the future of pharmaceutical and life science publishing industries
DESCRIPTION
The pharmaceutical and life science publishing industries have seen and will continue to see big changes over the next few years. Reallocation of library budgets, refocusing of R&D activities, generics and increased transparency in one; open access mandates, text-mining as a research requirement, and an explosion in mobile internet access globally in the other. There is also likely to be further consolidation and collaboration between "big beasts" of both industries as they adjust to changing revenues due to the growth of generics and open access. Both industries are also aware of the continued growth of innovation-led start-ups and disruptive technologies. Technological changes at the interface of pharma and STM Publishing: Mobile, Tablet and now wearable hardware such as Glass make things look even more interesting going forward. What does all this, and more, mean for the generation, processing, delivery and use of scientific content for the pharma and biotech industries?TRANSCRIPT
Life Sciences, The Contentverse and Publishing
Duncan Fraser
Director, Pharmaceutical & Biotech Markets
Life, Universe & Everything ICIC | 10/15/2014 | 2
A bit about me
• Biological Sciences background
• 22 years in “the Industry”
• Bookselling – Waterstone’s
• University Library – Edinburgh Univ
• STM Book Production – Taylor & Francis
• Society Publishing – BVA
• Medical education editorial – Elsevier
• Product management for MedEd, A&D/Oil&Gas & Biomedical – Elsevier, IHS, BioMed Central
• Market & Product Strategy Pharma/Biotech – Springer
Life Sciences…
Life, Universe & Everything ICIC | 10/15/2014 | 4
Changing strategies
• Originator examining their strategies post the 2012 patent cliff; R&D strategies are becoming more focussed
• Outsourcing is on the increase
• Generics
• Winning business models are being extended
• Expertise is being developed in key drug categories and/or therapeutic areas
• M&A activity is being used to strengthen leading positions
Life, Universe & Everything ICIC | 10/15/2014 | 5
Total Shareholder Return over past 20 years
Life, Universe & Everything ICIC | 10/15/2014 | 6
Leading a segment indicates increased profitability
Life, Universe & Everything ICIC | 10/15/2014 | 7
Pharma on the move
• Pfizer & AZ – shelved (?)
• GSK & Novartis – Strengthened GSK in vaccines, Novartis shored up it’s 2nd place in oncology, joint venture in OTC puts them ahead of J&J
• AbbVie & Shire – Tax inversion benefit for AbbVie plus acquistion of Shire’s portfolio
• Bayer & Merck & Co. – Now 2nd in OTC plus stronger position in cardiology
• Including budgets – from the library direct to Research and Development departments, Libraries shifting from collection curation to strategic information delivery including competitive intelligence
Life, Universe & Everything ICIC | 10/15/2014 | 8
Internal challenges
Regulatory burdens
Dealing with
processes
Dealing with
people
Dealing with information
ENVIRONMENTAL ORGANISATIONAL
Market economy and competition
within the industry
Life, Universe & Everything ICIC | 10/15/2014 | 9
Non-information-related challenges are considerable
• Industry is moving at a fast pace, restructuring globally (e.g. offshoring, consolidation, highly competitive)
• Hard to identify what to focus on (e.g. what targets, how to differentiate) and new ways to do things (e.g. in science)
Competition within the industry
• Growing compliance issues with big hurdles to jump and increasingly comprehensive legislation
• Heavy reporting requirements
Regulatory burdens
• Making the case internally for more resources or for their ROI
• The bureaucracy to get things done in large companies
• Global time differences and lack of control
Dealing with internal
processes
• Identifying and helping interdisciplinary teams work together
• Finding out what colleagues really need Dealing with
people
Life, Universe & Everything ICIC | 10/15/2014 | 10
Information-related challenges
• Filtering out the less relevant results from a search or from the alerts they receive
Noise
• Targeting the info they are really interested in
• Getting an overview of a new area Selectivity
• Staying up to date with the developments in their field
Currency
• Assessing the quality and accuracy or information Quality
• Lack of standardisation and comparability between database searches and outputs
Interoperability
• Pulling this all together; digesting and collating it
• Producing an easy to understand analysis Synthesis
Life, Universe & Everything ICIC | 10/15/2014 | 11
Just in Case Just Enough Just In
Time
Just for Me
Changing user needs
…The Contentverse…
Life, Universe & Everything ICIC | 10/15/2014 | 13
Big Data
Life, Universe & Everything ICIC | 10/15/2014 | 14
Big Data
Life, Universe & Everything ICIC | 10/15/2014 | 15
Big Content
“The number of research papers published yearly shows a staggering exponential growth. One can in fact witness a century-long publication avalanche...
According to the two major databases INSPEC and Thomson Reuters, there is a 300-fold increase in the
number of published items since the year 1900…”
Confined to grow? Publication dynamics and the proliferation of scientific journals
Europhysics News 45/1, 2014, p. 19–22
http://dx.doi.org/10.1051/epn/2014102
Life, Universe & Everything ICIC | 10/15/2014 | 16
What can be done to improve?
Life, Universe & Everything ICIC | 10/15/2014 | 17
Unmet information needs?
Can you predict the future? I think we all get too much
information being thrown
at us all the time!
…and Publishing.
Life, Universe & Everything ICIC | 10/15/2014 | 19
What’s the answer for Pharma?
A. More content
B. Less content
C. Focussed content
D. Content management tools
E. All of the above
Life, Universe & Everything ICIC | 10/15/2014 | 20
Just in Case Just Enough Just In
Time Just for
Me
Back to this again
Life, Universe & Everything ICIC | 10/15/2014 | 21
All of the above
• Analysis
• Thought leadership/opinion on what is important and why
• Flexibility
• More content, better positioned for those who want it
• Less content, focussed on specific areas or interest
• Enriched content
• Improved discovery
• Improved search functionality and results delivery
• Improved browse by creating more meaningful relationships between content sets
• Driving deeper engagement
• Get out of the way
• Data and text mining tools
Life, Universe & Everything ICIC | 10/15/2014 | 22
Thank you
Duncan Fraser Director, Pharmaceutical & Biotech Markets
---
Springer Science + Business Media 236 Gray’s Inn Road | London WC1X 8HB | UK
@duncfrase